MINT-LEVOCARB
MINT PHARMACEUTICALS INC
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of MINT-LEVOCARB in Canada?
Yes. MINT-LEVOCARB 25MG 250MG has an active shortage reported to Health Canada (last updated June 17, 2026).
Why is MINT-LEVOCARB not available?
The reason the manufacturer reported: Requirements related to complying with good manufacturing practices.
When will MINT-LEVOCARB be available again?
The manufacturer's estimated resolution date is November 30, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Contact your pharmacy before your current supply runs low, and ask your pharmacist about next steps if they're out.
DIN
02457970
Strength
25MG 250MG
Dosage Form
TABLET
Route
ORAL
Active Ingredient
CARBIDOPA LEVODOPA
Compare with another product →
Shortage Timeline
Approximate — based on the dates HPSC reports were last updated, not confirmed onset or resolution dates. Gaps between bars are periods with no shortage on file.
Shortage History
Other Products from MINT PHARMACEUTICALS INC
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
300MG · DIN 02480956
25MG · DIN 02468859
10MG · DIN 02468840
200MG · DIN 02524708
800MG · DIN 02524724
400MG · DIN 02524716
70.0MG · DIN 02394871
10MG · DIN 02362678
5MG · DIN 02362651
1MG · DIN 02393573
5MG · DIN 02495449
2.5MG · DIN 02495430